CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

BrainChild Bio gets $116M for pivotal trial of pediatric brain tumor CAR-T

Positive
AI Analysis

Summary

BrainChild Bio raised $116M to fund a pivotal trial of its CAR-T cell therapy for pediatric brain tumors. The company aims to advance toward commercial-stage status with this funding.

Clinical Trial Data

Phase

pivotal

Importance:6/10
Sentiment:
0.70
CAR-Tpediatric oncologybrain tumorfundraisingSeattle biotech
Related Companies

Read the original article

Published by Endpoints News on September 8, 2026 11:00 AM

Read Original